KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Emergent BioSolutions (EBS) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for Emergent BioSolutions (EBS) over the last 17 years, with Q3 2025 value amounting to $53.9 million.

  • Emergent BioSolutions' Shares Outstanding (Weighted Average) rose 150.66% to $53.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $53.9 million, marking a year-over-year increase of 150.66%. This contributed to the annual value of $53.0 million for FY2024, which is 351.56% up from last year.
  • Emergent BioSolutions' Shares Outstanding (Weighted Average) amounted to $53.9 million in Q3 2025, which was up 150.66% from $54.3 million recorded in Q2 2025.
  • Emergent BioSolutions' 5-year Shares Outstanding (Weighted Average) high stood at $54.4 million for Q1 2025, and its period low was $50.1 million during Q4 2022.
  • Its 5-year average for Shares Outstanding (Weighted Average) is $52.3 million, with a median of $52.6 million in 2024.
  • In the last 5 years, Emergent BioSolutions' Shares Outstanding (Weighted Average) tumbled by 651.77% in 2022 and then skyrocketed by 421.46% in 2025.
  • Over the past 5 years, Emergent BioSolutions' Shares Outstanding (Weighted Average) (Quarter) stood at $53.5 million in 2021, then decreased by 6.36% to $50.1 million in 2022, then increased by 2.2% to $51.2 million in 2023, then increased by 3.52% to $53.0 million in 2024, then rose by 1.7% to $53.9 million in 2025.
  • Its Shares Outstanding (Weighted Average) was $53.9 million in Q3 2025, compared to $54.3 million in Q2 2025 and $54.4 million in Q1 2025.